PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy.
about
Surgery for epilepsyMonoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target DrugsComparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humansEvaluation of magnetic resonance imaging-negative drug-resistant epilepsyRecent imaging advances in neurology.
P2860
PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 July 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy.
@en
PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy.
@nl
type
label
PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy.
@en
PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy.
@nl
prefLabel
PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy.
@en
PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy.
@nl
P2093
P2860
P1476
PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy
@en
P2093
Ashley R Martinez
Clarissa J Liew
Irene M Dustin
Sungyoung Auh
Susumu Sato
William H Theodore
P2860
P304
P356
10.2967/JNUMED.112.103093
P407
P577
2012-07-10T00:00:00Z